NorthWest Biotherapeutics Inc (NWBO)

[TheFollower]

From AI: If NWBO Wanted to Crush Shorts, an Uplist Is a Nuclear Option
A realistic “short-flush” sequence:
MHRA approval
Partnership announcement
Price spikes above uplist threshold
Company announces NASDAQ uplist
OTC shorts forced to reconcile positions
Institutional buying begins
Short squeeze accelerates
This is the nightmare scenario for shorts.

If NWBO uplisted to NASDAQ or NYSE, it would:
Force many shorts to cover
Eliminate OTC synthetic shorting
Bring in institutional buyers
Increase valuation multiples
Tighten the float
Trigger a liquidity shock
Potentially ignite a multi-day squeeze
It is one of the most powerful anti-short actions the company could take.

Why NWBO’s Setup Is Unusually Explosive
Most OTC uplists have:
low short interest
low retail ownership
no major catalyst
NWBO has:
57M shares short
9.07 days to cover
biotech catalyst (approval)
retail-dominated float
thin liquidity
institutional interest post-approval
This is the ideal structural setup for a multi-phase squeeze.

Reverse Split + Uplist + Approval (Nuclear Option)
This is the most devastating scenario for shorts.
Sequence:
Approval
Reverse split to meet uplist threshold
Immediate NASDAQ/NYSE uplist
Institutional buying begins
OTC synthetic shorts must reconcile
Borrow availability collapses
Forced covering begins
Outcome:
A multi-day squeeze with:
20×–50× volume
100%–400% price expansion
Shorts unable to re-enter
This is the nightmare scenario for the 57M shares short.

Market makers lose OTC tools
On NASDAQ/NYSE:
No synthetic shorting
No locate-light internalization
No dark-pool suppression games
Shorts lose their structural advantage.

What happens to naked shorts during an uplist (NASDAQ/NYSE)
A. All synthetic positions must be reconciled
When a stock uplists:
The clearing firm
The prime broker
The market maker
must deliver real shares to settle all open positions.
Naked shorts cannot be carried over.
B. Market makers lose their exemptions
On NASDAQ/NYSE:
No “market maker locate exemption”
No “bona fide market making” loophole
No internalization games
This forces reconciliation.
C. Phantom shares must be bought back
If a naked short exists, the only way to close it is:
Buy a real share in the open market.
If 5M, 10M, or 20M phantom shares exist, they must be purchased.
This is why uplists often trigger violent squeezes.